Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Health Care Resource, Economic, and Readmission Implications After Acute Decompensated Aortic Stenosis–A Nationwide Study

Patel, Kush P. ; Sawatari, Hiroyuki ; Chahal, Anwar ; Vuyisile, Nkomo T. ; Somers, Virend ; Mullen, Michael J. ; Ricci, Fabrizio LU and Khanji, Mohammed Y. (2023) In American Journal of Cardiology 204. p.200-206
Abstract

Acute decompensated aortic stenosis (ADAS) is common. The cumulative burden of ADAS from a clinical, health care resource, and financial perspective is unknown. This study sought to assess the national impact of ADAS compared with electively treated, stable patients with aortic stenosis (non-ADAS). Using the National Readmissions Database between 2016 and 2019, patients with ADAS and non-ADAS were identified using International Classification of Diseases, Tenth Revision codes. Patients with ADAS were propensity-matched to non-ADAS patients (1:2) using age, gender, and Charlson co-morbidity index. We compared in-hospital mortality, length of stay (LOS), health care–associated costs, and 90-day readmission data between the 2 cohorts. A... (More)

Acute decompensated aortic stenosis (ADAS) is common. The cumulative burden of ADAS from a clinical, health care resource, and financial perspective is unknown. This study sought to assess the national impact of ADAS compared with electively treated, stable patients with aortic stenosis (non-ADAS). Using the National Readmissions Database between 2016 and 2019, patients with ADAS and non-ADAS were identified using International Classification of Diseases, Tenth Revision codes. Patients with ADAS were propensity-matched to non-ADAS patients (1:2) using age, gender, and Charlson co-morbidity index. We compared in-hospital mortality, length of stay (LOS), health care–associated costs, and 90-day readmission data between the 2 cohorts. A total of 51,498 propensity-matched patients were included in this study: median age 75 years, 64% men. The in-hospital mortality for ADAS was higher than non-ADAS (2.8% vs 1.5%, p <0.0001). The LOS during the index admission was longer for ADAS (9 [5 to 13] vs 4 [2 to 6] days, p <0.0001). The health care–associated costs per patient was greater for ADAS ($55,450.0 [41,860.4 to 74,500.7] vs $43,405.7 [34,218.5 to 56,034.8], p <0.0001). Readmission to hospital within 90 days was more frequent in ADAS (21.1 vs 16.8%, p <0.001). The in-hospital mortality during readmission was higher with ADAS (3.9% vs 2.8%, p = 0.004). The readmission LOS was longer with ADAS (4 [2 to 7] vs 3 [2 to 6] days, p <0.0001). In conclusion, ADAS imposes a significant burden clinically and financially and on health care resources compared with non-ADAS during the index admission and 90-day follow-up. There is an urgent need to predict ADAS and optimize the timing of aortic valve replacement to reduce the incidence and the burden associated with ADAS.

(Less)
Please use this url to cite or link to this publication:
author
; ; ; ; ; ; and
organization
publishing date
type
Contribution to journal
publication status
published
subject
keywords
acute decompensated aortic stenosis, acute heart failure, aortic stenosis, surgical aortic valve replacement, TAVI, transcatheter aortic valve replacement
in
American Journal of Cardiology
volume
204
pages
7 pages
publisher
Excerpta Medica
external identifiers
  • scopus:85166977326
  • pmid:37544145
ISSN
0002-9149
DOI
10.1016/j.amjcard.2023.07.081
language
English
LU publication?
yes
id
b52338a0-c3c4-4bb7-a8f0-0ed71cc3c9a0
date added to LUP
2023-10-24 13:30:21
date last changed
2024-06-15 10:41:52
@article{b52338a0-c3c4-4bb7-a8f0-0ed71cc3c9a0,
  abstract     = {{<p>Acute decompensated aortic stenosis (ADAS) is common. The cumulative burden of ADAS from a clinical, health care resource, and financial perspective is unknown. This study sought to assess the national impact of ADAS compared with electively treated, stable patients with aortic stenosis (non-ADAS). Using the National Readmissions Database between 2016 and 2019, patients with ADAS and non-ADAS were identified using International Classification of Diseases, Tenth Revision codes. Patients with ADAS were propensity-matched to non-ADAS patients (1:2) using age, gender, and Charlson co-morbidity index. We compared in-hospital mortality, length of stay (LOS), health care–associated costs, and 90-day readmission data between the 2 cohorts. A total of 51,498 propensity-matched patients were included in this study: median age 75 years, 64% men. The in-hospital mortality for ADAS was higher than non-ADAS (2.8% vs 1.5%, p &lt;0.0001). The LOS during the index admission was longer for ADAS (9 [5 to 13] vs 4 [2 to 6] days, p &lt;0.0001). The health care–associated costs per patient was greater for ADAS ($55,450.0 [41,860.4 to 74,500.7] vs $43,405.7 [34,218.5 to 56,034.8], p &lt;0.0001). Readmission to hospital within 90 days was more frequent in ADAS (21.1 vs 16.8%, p &lt;0.001). The in-hospital mortality during readmission was higher with ADAS (3.9% vs 2.8%, p = 0.004). The readmission LOS was longer with ADAS (4 [2 to 7] vs 3 [2 to 6] days, p &lt;0.0001). In conclusion, ADAS imposes a significant burden clinically and financially and on health care resources compared with non-ADAS during the index admission and 90-day follow-up. There is an urgent need to predict ADAS and optimize the timing of aortic valve replacement to reduce the incidence and the burden associated with ADAS.</p>}},
  author       = {{Patel, Kush P. and Sawatari, Hiroyuki and Chahal, Anwar and Vuyisile, Nkomo T. and Somers, Virend and Mullen, Michael J. and Ricci, Fabrizio and Khanji, Mohammed Y.}},
  issn         = {{0002-9149}},
  keywords     = {{acute decompensated aortic stenosis; acute heart failure; aortic stenosis; surgical aortic valve replacement; TAVI; transcatheter aortic valve replacement}},
  language     = {{eng}},
  month        = {{10}},
  pages        = {{200--206}},
  publisher    = {{Excerpta Medica}},
  series       = {{American Journal of Cardiology}},
  title        = {{Health Care Resource, Economic, and Readmission Implications After Acute Decompensated Aortic Stenosis–A Nationwide Study}},
  url          = {{http://dx.doi.org/10.1016/j.amjcard.2023.07.081}},
  doi          = {{10.1016/j.amjcard.2023.07.081}},
  volume       = {{204}},
  year         = {{2023}},
}